Skip to main content
. 2021 Jul 21;129(4):423–433. doi: 10.1111/bju.15507

Table 2.

Analysis of the treatment ranking (OS and PFS).

Treatment P‐score (fixed) P‐score (random)
OS
Abiraterone 0.7666 0.7666
Apalutamide 0.6718 0.6718
Enzalutamide 0.6283 0.6283
Docetaxel 0.4170 0.4170
ADT 0.0163 0.0163
PFS
Enzalutamide 0.9613 0.9613
Abiraterone 0.6704 0.6704
Apalutamide 0.6148 0.6148
Docetaxel 0.2535 0.2535
ADT 0.0000 0.0000